Pfizer’s Obesity Push: Can Berobenatide Take Market Share?
The global obesity market is emerging as one of the largest growth opportunities in pharmaceuticals. The market is…
Pfizer’s Next Weight-Loss Weapon: How Berobenatide Stacks Up Against Novo Nordisk’s Wegovy and Eli Lilly’s Zepbound
The past few years have been rough on Pfizer (NYSE: PFE). The company has generally posted subpar financial…
In the Weight-Loss Wars, Novo’s Obesity Pill Is Pulling Way Ahead of Lilly’s
The launch of weight-loss pills is the hottest battle in pharma. So far, Eli Lilly LLY 1.15%increase; up…
Is Pfizer on Track to Launch Its Next Lipitor — This Time in the Weight-Loss Market?
Key Points Pfizer has regrouped in the GLP-1 space and is now working on a long-acting drug option.…
Forget Novo Nordisk. Pfizer’s Obesity Pipeline Is Coming, and It Pays You 6.8% While You Wait
Quick Read Pfizer beats EPS estimates for the fifth straight quarter, pays a 6.8% dividend yield, and advances…
Novo Nordisk (NYSE:NVO) Launches Pan European Obesity Research Push As Pfizer Closes In
Make better investment decisions with Simply Wall St’s easy, visual tools that give you a competitive edge. Novo…
Can Pfizer Take Share From Lilly & Novo Nordisk in the Obesity Space?
The global obesity market is one of the largest and fastest-growing opportunities in healthcare today. The market is…
Pfizer’s Monthly GLP-1 Drug Berobenatide Could Reshape the Weight Loss Market by 2035 – News and Statistics
Jun 12, 2026 Pharmaceutical giants Novo Nordisk and Eli Lilly continue to dominate the weight loss drug market,…
Pfizer’s New Weight-Loss Data Just Gave Eli Lilly and Novo Nordisk Investors Something to Worry About
Pharmaceutical giants Novo Nordisk (NYSE: NVO) and Eli Lilly (NYSE: LLY) are still the two titans of the…
Pfizer’s New Weight-Loss Data Just Gave Eli Lilly and Novo Nordisk Investors Something to Worry About
Key Points Pfizer aims to enter the weight loss drug market, and one platform should be the workhorse…
3 Deeply Undervalued Stocks You Can Buy for Less Than $100 Right Now
Key Points Shares of Pfizer, Novo Nordisk, and PDD Holdings trade at incredibly low valuations right now. These…
These 2 Stocks Have More Upside
Shares of Eli Lilly (NYSE: LLY) have risen 400% over the past five years. Novo Nordisk (NYSE: NVO)…